NR508 Week 4-Midterm 58 out of 60 = 96.7%
Summative Practice Exam 2025
UPDATE/PRACTICE QUESTIONS AND CORRECT
VERIFIED ANSWERS
Save
Terms in this set (129)
1. All states have title protection for NP
2. All but 5 states stat's board of nursing control
practice and licensure.
3. Scope of practice determined by individual NP
Roles and Responsibilities license of licensing jurisdiction.New prescribers must
of APRN know the rules
4. in 17 states, NPs have independent scope of
practice and prescriptive authority.
5.6 states have full autonomous practice and
prescriptive authority.
, 1. Best therapy
2. Least expensive
3. Least likely to cause ADR
4. Clear indication for drug?
5. Are drugs effective in treating disorder?
Clinical Judgement in
6. What is goal of therapy?
prescribing
7. Under what conditions is it determined that drug is
not meeting goal and change should be made?
8. Unnecessary duplications?
9. OTC be just as useful?
10. Cost?
1. Physician: can offer insight
2. Pharmacists: pharm knowledge
Collaboration with other 3. Other APRNs: clinical experience shared and
prescribers collaboration
4. PAs
5. RNs.
1. More states are broadening and expanding legal,
Autonomy and reimbursement, and prescriptive authority.
prescriptive authority 2. Gains can be reversed, so address concerns.
3. Some push for physician control.
1. Activation of central alpha 2 receptors results in
inhibition of cardioacceleration and vasoconstriction
centers in brain.
2. Lead to decrease in peripheral outflow of
norepinephrine which leads to decrease in:
a. peripheral resistance
Alpha2Agonists: MOA b. renal vascular resistance
c. heart rate
d. blood pressure
3. Decrease in BP is due to sympathetic function
therefore sodium retention and increased blood
volume may occur: give with diuretic.
4. Second or third line HTN drug treatment.
, 1. Clonidine
Alpha2Agonists: Drugs in 2. guanabenz
class 3. guanfacine
4. methyldopa.
Alpha2Agonists: Tx of withdrawal d/t ability to lower adrenergic
Clonidine, off-label use stimulation associated with withdrawal.
Oral and transdermal doses:
bradycardia, AV block, palpitations, tachycardia,
hallucinations, sleep disorders, contact dermatitis,
Alpha2Agonists: ADRs dry mouth, orthostatic hypotension, constipation,
nausea, urinary retention, decreased sexual activity,
weight gain, leg gramps, and thrombocytopenia.
MOST COMMON: dry mouth
Do not stop abruptly d/t lack of alpha 2 receptors
Alpha2Agonists:
impair homeostatic balance that regulates SNS:
Discontinue instructions
Gradual taper over 4 days.
Alpha2Agonists: 1. Used to treat HTN.
Guanabenz and 2. EXR guanfacine: ADHD
guanfacine
1. Parallels synthesis of norepinephrine (NE)
2. Stimulation by this metabolite: decrease in
sympathetic outflow to the heart, kidneys, and blood
vessels.
Alpha2Agonists:
3. End result: decreased in BP, peripheral resistance,
Methyldopa
HR, sl. decrease in CO. Produces renal vascular
resistance.
4. Positive coombs test
5. Rarely hemolytic anemia.
Summative Practice Exam 2025
UPDATE/PRACTICE QUESTIONS AND CORRECT
VERIFIED ANSWERS
Save
Terms in this set (129)
1. All states have title protection for NP
2. All but 5 states stat's board of nursing control
practice and licensure.
3. Scope of practice determined by individual NP
Roles and Responsibilities license of licensing jurisdiction.New prescribers must
of APRN know the rules
4. in 17 states, NPs have independent scope of
practice and prescriptive authority.
5.6 states have full autonomous practice and
prescriptive authority.
, 1. Best therapy
2. Least expensive
3. Least likely to cause ADR
4. Clear indication for drug?
5. Are drugs effective in treating disorder?
Clinical Judgement in
6. What is goal of therapy?
prescribing
7. Under what conditions is it determined that drug is
not meeting goal and change should be made?
8. Unnecessary duplications?
9. OTC be just as useful?
10. Cost?
1. Physician: can offer insight
2. Pharmacists: pharm knowledge
Collaboration with other 3. Other APRNs: clinical experience shared and
prescribers collaboration
4. PAs
5. RNs.
1. More states are broadening and expanding legal,
Autonomy and reimbursement, and prescriptive authority.
prescriptive authority 2. Gains can be reversed, so address concerns.
3. Some push for physician control.
1. Activation of central alpha 2 receptors results in
inhibition of cardioacceleration and vasoconstriction
centers in brain.
2. Lead to decrease in peripheral outflow of
norepinephrine which leads to decrease in:
a. peripheral resistance
Alpha2Agonists: MOA b. renal vascular resistance
c. heart rate
d. blood pressure
3. Decrease in BP is due to sympathetic function
therefore sodium retention and increased blood
volume may occur: give with diuretic.
4. Second or third line HTN drug treatment.
, 1. Clonidine
Alpha2Agonists: Drugs in 2. guanabenz
class 3. guanfacine
4. methyldopa.
Alpha2Agonists: Tx of withdrawal d/t ability to lower adrenergic
Clonidine, off-label use stimulation associated with withdrawal.
Oral and transdermal doses:
bradycardia, AV block, palpitations, tachycardia,
hallucinations, sleep disorders, contact dermatitis,
Alpha2Agonists: ADRs dry mouth, orthostatic hypotension, constipation,
nausea, urinary retention, decreased sexual activity,
weight gain, leg gramps, and thrombocytopenia.
MOST COMMON: dry mouth
Do not stop abruptly d/t lack of alpha 2 receptors
Alpha2Agonists:
impair homeostatic balance that regulates SNS:
Discontinue instructions
Gradual taper over 4 days.
Alpha2Agonists: 1. Used to treat HTN.
Guanabenz and 2. EXR guanfacine: ADHD
guanfacine
1. Parallels synthesis of norepinephrine (NE)
2. Stimulation by this metabolite: decrease in
sympathetic outflow to the heart, kidneys, and blood
vessels.
Alpha2Agonists:
3. End result: decreased in BP, peripheral resistance,
Methyldopa
HR, sl. decrease in CO. Produces renal vascular
resistance.
4. Positive coombs test
5. Rarely hemolytic anemia.
